ArticleBrain sciences2024
A Comparative Analysis of the Novel Conditional Deep Convolutional Neural Network Model, Using Conditional Deep Convolutional Generative Adversarial Network-Generated Synthetic and Augmented Brain Tumor Datasets for Image Classification.
Article in Brain sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Generative Adversarial Network and Chaotic Map-Based Multi-Layer Medical Image Encryption.Sensors (Basel, Switzerland) · 2026Article
- Visual design and digital transformation of imaging under artificial intelligence technology.Scientific reports · 2026Article
- A Review of Data Engineering in United States Healthcare Infrastructure.Healthcare (Basel, Switzerland) · 2026Review
- An Interpretable Multimodal Machine-Learning Model for Non-Invasive Preoperative Glioma Grading.Cancers · 2026Article
- Transforming Intracerebral Hemorrhage Care with Artificial Intelligence: Opportunities, Challenges, and Future Directions.Diagnostics (Basel, Switzerland) · 2026Review
- Longitudinal Cerebral Structural, Microstructural, and Functional Alterations After Brain Tumor Surgery for Early Detection of Recurrent Tumors.Biomedicines · 2025Article
- Malignant progression of MES-like cells mediated by COL22A1 in the spatial heterogeneity of glioblastoma.Discover oncology · 2025Article
- AI-Driven Innovations in Neuroradiology and Neurosurgery: Scoping Review of Current Evidence and Future Directions.Cancers · 2025Review
- Detection ofJournal of imaging · 2025Article
- Federated learning-based CT liver tumor detection using a teacher‒student SANet with semisupervised learning.BMC medical imaging · 2025Article
- Imaging Evaluation of Periarticular Soft Tissue Masses in the Appendicular Skeleton: A Pictorial Review.Journal of imaging · 2025Review
- Advancements in Radiology Report Generation: A Comprehensive Analysis.Bioengineering (Basel, Switzerland) · 2025Review
- AI-Driven Automated Blood Cell Anomaly Detection: Enhancing Diagnostics and Telehealth in Hematology.Journal of imaging · 2025Article
- AI-Powered Object Detection in Radiology: Current Models, Challenges, and Future Direction.Journal of imaging · 2025Review
- AI in 2D Mammography: Improving Breast Cancer Screening Accuracy.Medicina (Kaunas, Lithuania) · 2025Article
- DermViT: Diagnosis-Guided Vision Transformer for Robust and Efficient Skin Lesion Classification.Bioengineering (Basel, Switzerland) · 2025Article
- Automatic Analysis of Ultrasound Images to Estimate Subcutaneous and Visceral Fat and Muscle Tissue in Patients with Suspected Malnutrition.Diagnostics (Basel, Switzerland) · 2025Article
- Artificial Intelligence Applications in Pediatric Craniofacial Surgery.Diagnostics (Basel, Switzerland) · 2025Review
- Resection of Meningiomas Invading the Cavernous Sinus: Treatment Strategy and Clinical Outcomes.Cancers · 2025Article
- RISNet: A variable multi-modal image feature fusion adversarial neural network for generating specific dMRI images.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease prediction is greatly challenged by the scarcity of datasets and privacy concerns associated with real medical data. An approach that stands out to circumvent this hurdle is the use of synthetic data generated using Generative Adversarial Networks (GANs). GANs can increase data volume while generating synthetic datasets that have no direct link to personal information. This study pioneers the use of GANs to create synthetic datasets and datasets augmented using traditional augmentation techniques for our binary classification task. The primary aim of this research was to evaluate the performance of our novel Conditional Deep Convolutional Neural Network (C-DCNN) model in classifying brain tumors by leveraging these augmented and synthetic datasets. We utilized advanced GAN models, including Conditional Deep Convolutional Generative Adversarial Network (DCGAN), to produce synthetic data that retained essential characteristics of the original datasets while ensuring privacy protection. Our C-DCNN model was trained on both augmented and synthetic datasets, and its performance was benchmarked against state-of-the-art models such as ResNet50, VGG16, VGG19, and InceptionV3. The evaluation metrics demonstrated that our C-DCNN model achieved accuracy, precision, recall, and F1 scores of 99% on both synthetic and augmented images, outperforming the comparative models. The findings of this study highlight the potential of using GAN-generated synthetic data in enhancing the training of machine learning models for medical image classification, particularly in scenarios with limited data available. This approach not only improves model accuracy but also addresses privacy concerns, making it a viable solution for real-world clinical applications in disease prediction and diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.